Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Dermatology/Plastic Surgery
Disease Category: Eczema (Atopic Dermatitis - Pediatric)

Trial Information

Pediatric Eczema Elective Registry (PEER Program)

Novartis Pharmaceuticals Corporation is sponsoring a Pediatric Eczema Elective Registry (PEER) to monitor the long-term safety of topical calcineurin inhibitors. This scientific observational registry is designed to collect information from the parents of approximately 5000 children across the USA between the ages of 2 years and 17 years (at enrollment) who have used and may continue to use Elidel® for the treatment of eczema.
For more information on this program, please visit

Research Center
Located In:
Various Cities, IL

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.